The cardiac risk score is the flashiest of several new genetic tests in the works, including ones that assess the risk that someone will have a stroke, that breast cancer will recur or that a hepatitis C patient will progress to cirrhosis.
Tests in mice showed it works against both A and B influenza types and known resistant flu strains and researchers are now doing tests in other animals.